Stockscreener 앱 받기
18.01
0.06%
0.01
시간 외 거래:
18.01
전일 마감가:
$18.00
열려 있는:
$17.98
하루 거래량:
1.12M
Relative Volume:
2.90
시가총액:
$792.59M
수익:
$159.01M
순이익/손실:
$-21.72M
주가수익비율:
-34.63
EPS:
-0.52
순현금흐름:
$-20.63M
1주 성능:
-0.66%
1개월 성능:
-0.72%
6개월 성능:
+43.85%
1년 성능:
+73.67%
1일 변동 폭
$17.10
$18.61
1주일 범위
$17.10
$19.19
52주 변동 폭
$5.55
$19.19
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
AXGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
18.01 | 792.59M | 159.01M | -21.72M | -20.63M | -0.52 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-01 | 개시 | Raymond James | Outperform |
| 2022-11-11 | 재개 | Jefferies | Buy |
| 2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | Guggenheim | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 개시 | Canaccord Genuity | Buy |
| 2018-03-02 | 재확인 | Lake Street | Buy |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 개시 | Jefferies | Buy |
| 2017-11-21 | 재확인 | Lake Street | Buy |
| 2017-07-31 | 개시 | Leerink Partners | Outperform |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 개시 | ROTH Capital | Buy |
| 2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
| 2016-11-07 | 재확인 | Wedbush | Outperform |
| 2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
| 2016-08-04 | 재확인 | Wedbush | Outperform |
| 2014-05-14 | 개시 | Dawson James | Buy |
| 2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
AxoGen (AXGN) Expected to Announce Earnings on Tuesday - Defense World
Objective long/short (AXGN) Report - Stock Traders Daily
Axogen, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025 - GlobeNewswire
Axogen's Pivotal Earnings Reveal: Q4 & 2024 Performance Deep Dive Coming Soon - StockTitan
AxoGen (NASDAQ:AXGN) Hits New 52-Week HighHere's Why - MarketBeat
Calamos Advisors LLC Makes New $523,000 Investment in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Canaccord raises AxoGen stock price target to $22 from $18 By Investing.com - Investing.com Nigeria
AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 - MarketBeat
Short Interest in AxoGen, Inc. (NASDAQ:AXGN) Increases By 20.4% - MarketBeat
Axogen appoints new VP of Regulatory Affairs - MSN
PepsiCo Reports Mixed Financial Results - The Globe and Mail
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by SG Americas Securities LLC - Defense World
AxoGen (NASDAQ:AXGN) Price Target Raised to $22.00 at Canaccord Genuity Group - Defense World
Morgan Stanley Reduces Stake in Axogen Inc: A Detailed Analysis - GuruFocus.com
Axogen Announces Appointment of Jesse Bishop as Vice - GlobeNewswire
Canaccord raises AxoGen stock price target to $22 from $18 - MSN
AxoGen appoints Jesse Bishop as VP, regulatory affairs - TipRanks
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
From Army Ranger to Biotech Executive: Special Ops Veteran Takes Helm of Axogen's Regulatory Strategy - StockTitan
Axogen stock soars to 52-week high, touches $18.99 - MSN
Cantor Fitzgerald Lowers Earnings Estimates for AxoGen - ETF Daily News
Trend Tracker for (AXGN) - Stock Traders Daily
Cantor Fitzgerald Weighs in on AxoGen FY2024 Earnings - Defense World
FY2024 EPS Estimates for AxoGen Lowered by Cantor Fitzgerald - MarketBeat
AxoGen (NASDAQ:AXGN) Reaches New 1-Year HighHere's Why - MarketBeat
Axogen stock soars to 52-week high, touches $18.99 By Investing.com - Investing.com Australia
AxoGen (NASDAQ:AXGN) Reaches New 1-Year High – Time to Buy? - Defense World
Axogen (FRA:LT3) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com
Axogen (FRA:LT3) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025) - GuruFocus.com
Assenagon Asset Management S.A. Sells 484,570 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen (NASDAQ:AXGN) Reaches New 12-Month HighShould You Buy? - MarketBeat
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? - MSN
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Has $7.70 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
Barclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? - MSN
Is Axogen (NASDAQ:AXGN) Using Too Much Debt? - Simply Wall St
Learn to Evaluate (AXGN) using the Charts - Stock Traders Daily
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
0.57%
자본화:
|
볼륨(24시간):